Tech Company Financing Transactions
Solugen Funding Round
Solugen closed a $32 million Series B funding round on 5/23/2019. Investors included Founders Fund, Fifty Years and KdT Ventures.
Transaction Overview
Company Name
Announced On
5/23/2019
Transaction Type
Venture Equity
Amount
$32,000,000
Round
Series B
Investors
Founders Fund (Lead Investor) (Brian Singerman)
Fifty Years (Seth Bannon)
Refactor Capital (David Lee)
Proceeds Purpose
The capital will be used to continue fueling Solugen's rapid growth as it seeks to decarbonize the chemicals industry with its bio-based technologies.
Company Information
Company Status
Private & Independent
Industry
Advanced Materials
Mailing Address
14549 Minetta St.
Houston, TX 77035
USA
Houston, TX 77035
USA
Phone
Website
Email Address
Overview
Our patented approach takes advantage of bio-inspired reactions to uses plant starch as a low-cost feedstock to produce chemicals through an extremely efficient synthesis reaction.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gaurab Chakrabarti
Chief Operating Officer
Travis Thibodeaux
Chief Technical Officer
Sean Hunt
Controller
Alan Pike
Vice President
Frederyk Ngantung
VP - General Counsel
Karina Amelang
Browse more venture capital transactions:
Prev: 5/23/2019: Inhibrx venture capital transaction
Next: 5/23/2019: Modsy venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here come from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs